New Publications


 Chen G, Xu R, Zhang S, Wang Y, Wang P, Edin ML, Zeldin DC, Wang DW. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice. Am J Physiol Endocrinol Metab. 308, E97-E110, 2015.


BioTarget™ Hypertension ELISA

Our Hypertension/Stroke ELISA (14,15-DHET) Kit has outstanding sensitivity for detection of soluble epoxide hydrolase-and/or UDP-glucuronosyl transferase- dependent hypertensions and development of new hypertension drugs.


Vasodilation • Tumorigenesis
• Angiogenesis • Vascular permeability
• Cell proliferation • Cell migration • Atherosclerosis 

Good Morning Detroit

September 21, 2016, 9 AM Special topic for September: HeaYeon Lee, Ph.D., Director of Nanotechnology, Detroit R&D/President, Mara Nanotech, will talk on "Digital Nanobiomedical System for Personalized Nanomedicine"

Click here for more information

Dietary Supplements

Coming Soon!

Contact Us


Invest in cutting edge technology.

Learn More

About Us

Detroit R&D (DRD) is an NIH SBIR-sponsored company that specializes in the development and manufacture of ELISA, antibodies and assay kits for research, diagnosis and treatment of cardiovascular disease and cancer.

Learn More

Hypertension Biomarkers and Drug Development

We developed and patented Novel Blood and Urine Hypertension Biomarkers and Drug Development Technologies (Patents and References). FDA clearance and CLIA waiver of the validated technologies are in progress. Please contact us for collaboration, licensing-in or investment.

Learn More

No front page content has been created yet.

New Products

Citrate Synthase Enzyme Assay
Mitochondrial Copy Number Assay Kits
GloBrite™ ECL Reagent Kit for Western Blotting


ThermoFisher Scientific

Get Fast, Direct Shipment.

Shop Now